Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Single Cell Analysis Summit

Nancy Allbritton's Biography



Nancy Allbritton, Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering, University of Washington in Seattle

Nancy L. Allbritton is the Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering at the University of Washington in Seattle.

Her research focuses on the development of novel technologies for applications in single-cell analysis, micro-arrays and fluidics, and organ-on-chip and has resulted in over 180 full-length journal publications and patents and led to 15 commercial products. Her research program has been well funded by the National Institutes of Health with $60 million in grant funding since 1994. Four companies have been formed based on her research discoveries: Protein Simple (acquired by Bio-Techne in 2014 for $308M), Intellego (subsequently integrated into International Rectifier), Cell Microsystems (www.cellmicrosystems.com), and Altis Biosystems (www.altisbiosystems.com). Dr. Allbritton is a Fellow of the American Association for the Advancement of Science, the American Institute for Medical & Biological Engineering, and the National Academy of Inventors. She obtained her B.S. in physics from Louisiana State University, M.D. from Johns Hopkins University, and Ph.D. in Medical Physics/Medical Engineering from the Massachusetts Institute of Technology, with a postdoctoral fellowship at Stanford University.

Nancy Allbritton Image

Microengineered Devices for Single Cell Analysis in Preclinical and Clinical Research

Friday, 13 September 2013 at 15:00

Add to Calendar ▼2013-09-13 15:00:002013-09-13 16:00:00Europe/LondonMicroengineered Devices for Single Cell Analysis in Preclinical and Clinical ResearchSingle Cell Analysis Summit in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.com

Microanalytical platforms in both array and microfluidic formats are being developed to address critical preclinical and clinical needs to accurately monitor drug action and identify the patient who will respond to new therapies aimed at modulating signal transduction pathways.


Add to Calendar ▼2013-09-12 00:00:002013-09-13 00:00:00Europe/LondonSingle Cell Analysis SummitSingle Cell Analysis Summit in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.com